Literature DB >> 16962735

An LNA-based loss-of-function assay for micro-RNAs.

I Naguibneva1, M Ameyar-Zazoua, N Nonne, A Polesskaya, S Ait-Si-Ali, R Groisman, M Souidi, L L Pritchard, A Harel-Bellan.   

Abstract

MicroRNAs (miRNAs) have recently emerged as being essential for development and for the control of cell proliferation/differentiation in various organisms. However, little is known about miRNA function and mode of action at the cellular level. We have designed a miRNA loss-of-function assay, based on chemically modified locked nucleic acids (LNA) antisense oligonucleotides and usable in tissue culture cells. We show that LNA/DNA mixed oligonucleotides form highly stable duplexes with miRNAs in vitro. Ex vivo, the target miRNA becomes undetectable in cells transfected with the antisense oligonucleotide. The effect is dose-dependent, long-lasting, and specific. Moreover, using a reporter assay, we show that antisense LNA/DNA oligonucleotides inhibit short non-coding RNAs at the functional level. Thus LNA/DNA mixmers represent powerful tools for functional analysis of miRNAs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16962735     DOI: 10.1016/j.biopha.2006.07.078

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  19 in total

1.  Applications of microRNA in cancer: Exploring the advantages of miRNA.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2009-06       Impact factor: 4.689

2.  microRNA-31 modulates skeletal patterning in the sea urchin embryo.

Authors:  Nadezda A Stepicheva; Jia L Song
Journal:  Development       Date:  2015-09-23       Impact factor: 6.868

Review 3.  Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications.

Authors:  George A Calin; Carlo M Croce
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

4.  LNA-based oligonucleotide electrotransfer for miRNA inhibition.

Authors:  Sophie Chabot; Julie Orio; Romain Castanier; Elisabeth Bellard; Søren J Nielsen; Muriel Golzio; Justin Teissié
Journal:  Mol Ther       Date:  2012-05-22       Impact factor: 11.454

5.  The WEE1 regulators CPEB1 and miR-15b switch from inhibitor to activators at G2/M.

Authors:  Gueorgui Kratassiouk; Linda L Pritchard; Sylvain Cuvellier; Andrii Vislovukh; Qingwei Meng; Regina Groisman; Cindy Degerny; Evgeny Deforzh; Annick Harel-Bellan; Irina Groisman
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

Review 6.  Alternate approaches to repress endogenous microRNA activity in Arabidopsis thaliana.

Authors:  Andrew L Eamens; Ming-Bo Wang
Journal:  Plant Signal Behav       Date:  2011-03-01

7.  Mammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis.

Authors:  Yuting Sun; Yejing Ge; Jenny Drnevich; Yong Zhao; Mark Band; Jie Chen
Journal:  J Cell Biol       Date:  2010-06-21       Impact factor: 10.539

8.  miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates.

Authors:  Martin M Fabani; Michael J Gait
Journal:  RNA       Date:  2007-12-11       Impact factor: 4.942

Review 9.  MicroRNAs--the micro steering wheel of tumour metastases.

Authors:  Milena S Nicoloso; Riccardo Spizzo; Masayoshi Shimizu; Simona Rossi; George A Calin
Journal:  Nat Rev Cancer       Date:  2009-03-05       Impact factor: 60.716

10.  Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells.

Authors:  Takeshi Haraguchi; Yuka Ozaki; Hideo Iba
Journal:  Nucleic Acids Res       Date:  2009-02-17       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.